Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Ho

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Journal of Cancer|April 12, 2011
In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude miceMingqian Feng, Jingli Zhang, Miriam Anver, et al.
Antibody Therapeutics|July 17, 2020
Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical ApplicationsYong Zhu, Run Shen, Rui Hao, et al.
Antibody Therapeutics|January 17, 2020
Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody SocietyHongyu Zhang, Mi Deng, Fen Pei, et al.
Journal of Cancer|November 2, 2011
Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapyYen T Phung, Dario Barbone, V Courtney Broaddus, et al.
International Journal of Cancer|July 17, 2010
A novel high-affinity human monoclonal antibody to mesothelinMitchell Ho, Mingqian Feng, Robert J Fisher, et al.
Mabs|January 13, 2010
Identification and characterization of fully human anti-CD22 monoclonal antibodiesXiaodong Xiao, Mitchell Ho, Zhongyu Zhu, et al.
Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastomaNan Li, Haiying Fu, Stephen M Hewitt, et al.
Tissue Engineering. Part C, Methods|August 3, 2010
Transwells with microstamped membranes produce micropatterned two-dimensional and three-dimensional co-culturesYu-Suke Torisawa, Bobak Mosadegh, Stephen P Cavnar, et al.
Antibody Therapeutics|November 20, 2020
COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19Lifei Yang, Weihan Liu, Xin Yu, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Journal of Cancer|April 12, 2011
In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude miceMingqian Feng, Jingli Zhang, Miriam Anver, et al.
Antibody Therapeutics|July 17, 2020
Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical ApplicationsYong Zhu, Run Shen, Rui Hao, et al.
Antibody Therapeutics|January 17, 2020
Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody SocietyHongyu Zhang, Mi Deng, Fen Pei, et al.
Journal of Cancer|November 2, 2011
Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapyYen T Phung, Dario Barbone, V Courtney Broaddus, et al.
International Journal of Cancer|July 17, 2010
A novel high-affinity human monoclonal antibody to mesothelinMitchell Ho, Mingqian Feng, Robert J Fisher, et al.
Mabs|January 13, 2010
Identification and characterization of fully human anti-CD22 monoclonal antibodiesXiaodong Xiao, Mitchell Ho, Zhongyu Zhu, et al.
Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastomaNan Li, Haiying Fu, Stephen M Hewitt, et al.
Tissue Engineering. Part C, Methods|August 3, 2010
Transwells with microstamped membranes produce micropatterned two-dimensional and three-dimensional co-culturesYu-Suke Torisawa, Bobak Mosadegh, Stephen P Cavnar, et al.
Antibody Therapeutics|November 20, 2020
COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19Lifei Yang, Weihan Liu, Xin Yu, et al.
Pageof 15